Discontinuation report MINT-DORZOLAMIDE/TIMOLOL
| Report ID | 85525 |
| Drug Identification Number | 02443090 |
| Brand name | MINT-DORZOLAMIDE/TIMOLOL |
| Common or Proper name | Dorzolomide Timolol |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
| Strength(s) | 5MG 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 10 ml |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-05-31 |
| Remaining supply date | 2019-05-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-06-04 | English | Compare |
| v2 | 2019-06-04 | French | Compare |
Showing 1 to 2 of 2